- The potential renoprotection of xanthine oxidase inhibitors: Febuxostat versus allopurinol
-
Ryu DR
- KMID: 2416089
- Kidney Res Clin Pract.
- 2017 Sep;36(3):207-208.
- doi: 10.23876/j.krcp.2017.36.3.207
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy and Safety of Febuxostat in Korean Patients with Gout
-
Lee SW
- KMID: 2223002
- J Rheum Dis.
- 2013 Oct;20(5):277-279.
- doi: 10.4078/jrd.2013.20.5.277
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Efficacy and Safety of Febuxostat and Allopurinol in the Treatment of Hyperuricemia: A Bayesian Network Meta-analysis
-
Song GG, Lee YH
- KMID: 2222809
- J Rheum Dis.
- 2015 Dec;22(6):356-365.
- doi: 10.4078/jrd.2015.22.6.356
OBJECTIVE: The aim of this study was to assess the relative urate-lowering efficacy and safety of febuxostat and allopurinol in hyperuricemic patients with or without gout. METHODS: Randomized controlled trials (RCTs)... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Efficacy and Safety of Febuxostat in Gout Patients with Chronic Kidney Disease Stage 3 and Stage 4/5
-
Ahn E, Lee S, Lee HN, Lee SG, So MW
- KMID: 2442022
- J Rheum Dis.
- 2019 Apr;26(2):118-123.
- doi: 10.4078/jrd.2019.26.2.118
OBJECTIVE: To compare efficacy and safety of febuxostat in gouty patients with chronic kidney disease (CKD) stage 3 and stage 4/5. METHODS: Age and sex matched patients with CKD stage 3... -
- CITED
-
- Close
- SHARE
-
- Close
- Febuxostat for the Treatment of Chronic Tophaceous Gout in a Patient on Continuous Ambulatory Peritoneal Dialysis
-
Yun JH, Kim HY, Kim DH, Oh JS, Kim SM, Sin YH, Kim JK
- KMID: 2269035
- Korean J Med.
- 2015 Aug;89(2):229-232.
- doi: 10.3904/kjm.2015.89.2.229
Hyperuricemic patients with gouty arthritis or tophi, a serum uric acid concentration of 8.0 mg/dL or higher, and complications should be treated with urate-lowering drugs. Conventionally, allopurinol is used to... -
- CITED
-
- Close
- SHARE
-
- Close
- Giant Tophi Involving Both Suprapatellar Pouches and Upper Poles of the Patellae: Treatment with Febuxostat and the 6 Years Follow-Up
-
Kim ST, Lee SY, Kim SJ, Kim BS
- KMID: 2438970
- J Korean Orthop Assoc.
- 2019 Feb;54(1):78-83.
- doi: 10.4055/jkoa.2019.54.1.78
Tophi is one of the clinical manifestations of gout. On the other hand, it does not draw the patient's attention when it is asymptomatic, which leads to delayed management. The... -
- CITED
-
- Close
- SHARE
-
- Close
- What is the Best Choice for Urate-lowering Therapy for Korean?
-
Cheon YH, Song JS
- KMID: 2471948
- J Rheum Dis.
- 2020 Apr;27(2):78-87.
- doi: 10.4078/jrd.2020.27.2.78
Gout is one of the most common forms of acute inflammatory arthritis caused by long-standing hyperuricemia. Various clinical and epidemiological studies have demonstrated that uric acid, which is strongly associated... -
- CITED
-
- Close
- SHARE
-
- Close
- The Urate-lowering Efficacy and Safety of Febuxostat in Korean Patients with Gout
-
Park SH, Song YW, Park W, Koh EM, Yoo B, Lee SK, Yoo DH, Lee YJ, Kim HA, Choi HJ, Kim HY, Jung HG
- KMID: 2297536
- J Rheum Dis.
- 2013 Aug;20(4):223-230.
- doi: 10.4078/jrd.2013.20.4.223
OBJECTIVE: To compare the urate-lowering efficacy and the safety of febuxostat, allopurinol and placebo in Korean patients with gout for 4 weeks. METHODS: Subjects (n=182) with gout were randomized to febuxostat... -
- CITED
-
- Close
- SHARE
-
- Close
- Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis
-
Kim S, Kim HJ, Ahn HS, Oh SW, Han KH, Um TH, Cho CR, Han SY
- KMID: 2416097
- Kidney Res Clin Pract.
- 2017 Sep;36(3):274-281.
- doi: 10.23876/j.krcp.2017.36.3.274
BACKGROUND: Hyperuricemia is reported to be related to rapid progression of renal function in patients with chronic kidney disease (CKD). Allopurinol, a uric acid lowering agent, protects renal progression. However,... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence and possible causes of hypouricemia at a tertiary care hospital
-
Son CN, Kim JM, Kim SH, Cho SK, Choi CB, Sung YK, Kim TH, Bae SC, Yoo DH, Jun JB
- KMID: 2350987
- Korean J Intern Med.
- 2016 Sep;31(5):971-976.
- doi: 10.3904/kjim.2015.125
BACKGROUND/AIMS: We aimed to investigate the prevalence and possible causes of hypouricemia in the Korean population and to compare our findings with published results of other populations. METHODS: We examined the... -
- CITED
-
- Close
- SHARE
-
- Close
- An update on the management of hyperuricemia and gout
-
Jung YO
- KMID: 2257615
- Korean J Med.
- 2009 May;76(5):538-543.
Gout is a common chronic inflammatory arthritis that can lead to significant disability. Gout is one of the few rheumatologic diseases that can be diagnosed with certainty and can be... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Progress in the Management of Gouty Arthritis and Hyperuricemia
-
Park W
- KMID: 2258990
- Korean J Med.
- 2011 Mar;80(3):260-268.
There is an increasing incidence of gout and hyperuricemia worldwide. It is because the population is getting older, their life style is sedentary, and they take protein-enriched food. Gout is... -
- CITED
-
- Close
- SHARE
-
- Close
- Updates in the management of gouty arthritis
-
Choi IA, Hong SJ
- KMID: 2257325
- Korean J Med.
- 2009 Feb;76(2):151-162.
Gout is the most common inflammatory arthritis in men over 40 years old and the prevalence is increasing. Asymptomatic hyperuricemia is predisposing condition of gout but the frequency of progression... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnosis and Treatment of Inflammatory Joint Disease
-
Kim Y, Oh HC, Park JW, Kim IS, Kim JY, Kim KC, Chae DS, Jo WL, Song JH
- KMID: 2424246
- Hip Pelvis.
- 2017 Dec;29(4):211-222.
- doi: 10.5371/hp.2017.29.4.211
Arthritis damages the cartilage within joints, resulting in degenerative changes, including loss of function and joint instability. Ankylosing spondylitis (AS) is a chronic inflammatory condition affecting the spine and bone-to-tendon... -
- CITED
-
- Close
- SHARE
-
- Close
- Physicians' perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey
-
Cha RH, Kim SH, Bae EH, Yu M, Choi BS, Choi HY, Kang SW, Shin J, Han SY, Yang CW, Kang DH
- KMID: 2457729
- Kidney Res Clin Pract.
- 2019 Sep;38(3):373-381.
- doi: 10.23876/j.krcp.19.007
BACKGROUND: Hyperuricemia is associated with the development and progression of chronic kidney disease (CKD) as well as cardiovascular diseases. However, there is no consistent recommendation regarding the treatment of asymptomatic... -
- CITED
-
- Close
- SHARE
-
- Close
